網膜剥離診断市場- 世界の産業規模、シェア、動向、機会、予測、疾患タイプ別、診断法別、地域別セグメント、競合、2020年～2030年

網膜剥離診断の世界市場規模は2024年に21億米ドルとなり、2030年までのCAGRは5.45%で、堅調な成長が予測されています。

世界の網膜剥離診断市場は、より広範な眼科・眼科医療分野の中でも重要なセグメントであり、主に網膜剥離（網膜が下の組織から剥がれ落ちる視力を脅かす状態）の診断と早期発見に焦点を当てています。この市場には、網膜剥離や関連疾患を特定・評価するためにヘルスケア専門家が使用する様々な診断ツール、技術、サービスが含まれます。

世界の網膜剥離診断市場は、いくつかの重要な要因により着実に成長しています。世界的に高齢化が進むにつれ、網膜剥離やその他の網膜疾患の有病率が上昇し、診断サービスや機器の需要が高まっています。さらに、目の健康に対する意識の高まりと定期的な眼科検診の重要性が、早期診断と早期治療を求める個人を促し、市場の成長に寄与しています。

診断機器の技術的進歩により、網膜剥離診断の精度と効率が大幅に向上しています。光干渉断層計（OCT）、眼底写真、超音波などの高解像度画像技術はこの分野に革命をもたらし、医療従事者が網膜の異常をより正確に検出できるようになりました。これにより、早期介入と患者の転帰の改善が促進されます。

市場促進要因

網膜疾患の有病率の増加

主な市場課題

コスト制約

主な市場動向

遠隔医療と遠隔モニタリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 網膜剥離診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 疾患タイプ別（裂孔原性網膜剥離、滲出性網膜剥離、漿液性網膜剥離、二次性網膜剥離、牽引性網膜剥離）
  • 診断法別（眼底写真、眼底検査、デジタル網膜カメラ、蛍光網膜血管造影、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の網膜剥離診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の網膜剥離診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の網膜剥離診断市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の網膜剥離診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの網膜剥離診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の網膜剥離診断市場：SWOT分析

第14章 競合情勢

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation（Centervue SpA）
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems（Synergy Medical）LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Retinal Detachment Diagnostic Market was valued at USD 2.10 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.45% through 2030. The Global Retinal Detachment Diagnostics Market is a crucial segment within the broader ophthalmology and eye care sector, primarily focusing on the diagnosis and early detection of retinal detachment-a sight-threatening condition where the retina peels away from the underlying tissue. This market encompasses various diagnostic tools, technologies, and services used by healthcare professionals to identify and assess retinal detachment and related disorders.

The Global Retinal Detachment Diagnostics Market has been steadily growing due to several key factors. As the aging population increases worldwide, the prevalence of retinal detachment and other retinal disorders rises, thereby driving the demand for diagnostic services and equipment. Additionally, the growing awareness of eye health and the importance of regular eye check-ups have prompted individuals to seek early diagnosis and treatment, contributing to market growth.

Technological advancements in diagnostic devices have significantly improved the accuracy and efficiency of retinal detachment diagnosis. High-resolution imaging techniques like Optical Coherence Tomography (OCT), fundus photography, and ultrasound have revolutionized the field, enabling healthcare professionals to detect retinal abnormalities with greater precision. This, in turn, fosters early intervention and improved patient outcomes.

Key Market Drivers

Increasing Prevalence of Retinal Disorders

The growing prevalence of retinal disorders is a major driver fueling the expansion of the global retinal detachment diagnostic market. As the incidence of vision-related diseases continues to rise worldwide, the demand for early detection, accurate diagnosis, and preventive screening has increased significantly. This trend is primarily driven by factors such as the rising diabetic population, aging demographics, increased cases of high myopia, and lifestyle-related ocular diseases. Diabetes is one of the most significant risk factors for retinal detachment, as it leads to diabetic retinopathy-a condition that damages retinal blood vessels and can progress to tractional retinal detachment (TRD) if left untreated. According to the IDF Diabetes Atlas (2021), 10.5% of the global adult population (aged 20-79 years) is affected by diabetes, with nearly 50% of cases going undiagnosed. This silent health crisis has significant implications for healthcare systems and diagnostic markets worldwide.

Projections indicate a 46% surge in diabetes cases by 2045, with 1 in 8 adults-approximately 783 million people-expected to be diabetic. This rapid escalation will drive higher demand for early screening technologies, retinal diagnostics, and preventive healthcare solutions, positioning the ophthalmic diagnostics sector for substantial growth in the coming decades. As diabetic patients are advised to undergo routine eye examinations, the demand for advanced retinal imaging diagnostics such as Optical Coherence Tomography (OCT), Fundus Photography, and Fluorescein Angiography has grown exponentially. Many governments and healthcare organizations have implemented diabetic eye screening initiatives to prevent vision loss, further driving demand for retinal diagnostic devices. As diabetes cases continue to surge, the retinal detachment diagnostic market is witnessing higher adoption of diagnostic technologies across hospitals, clinics, and telemedicine platforms.

The aging global population is a significant contributor to the rising prevalence of retinal detachment and related disorders. Older individuals are more prone to posterior vitreous detachment (PVD), a common precursor to retinal detachment. As life expectancy increases, age-related macular degeneration (AMD) is becoming a leading cause of vision impairment, requiring frequent retinal monitoring. In elderly individuals, the vitreous gel inside the eye shrinks, leading to retinal tears and detachment, increasing the demand for early diagnostic imaging. By 2050, an estimated 80% of the global elderly population will reside in low- and middle-income countries, signaling a demographic shift with profound economic and healthcare implications.

Key Market Challenges

Cost Constraints

One of the significant challenges facing the growth of the Global Retinal Detachment Diagnostic market is cost constraints. State-of-the-art diagnostic technologies, such as Optical Coherence Tomography (OCT) and high-resolution fundus cameras, are integral to accurate retinal detachment diagnosis. These advanced technologies often come with a substantial price tag. The cost of acquiring, maintaining, and upgrading such equipment can be prohibitive for smaller healthcare facilities and clinics, limiting their ability to provide comprehensive retinal diagnostics. In many regions, healthcare budgets are limited, and healthcare providers must allocate resources across various medical specialties. As a result, ophthalmology departments may struggle to secure funding for the purchase and maintenance of expensive retinal diagnostic equipment. This limitation can lead to inadequate access to retinal examinations in underserved areas. Reimbursement policies and rates for retinal diagnostic tests can vary significantly by country and region. In some cases, reimbursement may not cover the full cost of the diagnostic procedure, leaving healthcare providers with financial burdens. This can discourage facilities from investing in advanced retinal diagnostics and hinder market growth.

Key Market Trends

Telemedicine and Remote Monitoring

Advances in telemedicine technology have enabled ophthalmologists and retinal specialists to conduct virtual consultations with patients. Through video conferencing and digital imaging, healthcare providers can assess retinal health, monitor progression, and offer guidance remotely. This trend has become particularly important during the COVID-19 pandemic when in-person visits were limited. The emergence of wearable devices, such as smartphone-based fundus cameras and portable OCT devices, allows patients to capture retinal images at home. These images can be securely transmitted to healthcare providers for assessment. This trend not only enhances patient convenience but also facilitates early detection and continuous monitoring of retinal conditions. The data generated through telemedicine and remote monitoring can be analyzed using artificial intelligence (AI) algorithms. AI-powered software can assist in the early identification of retinal abnormalities and trends, improving diagnostic accuracy and enabling timely interventions. This data-driven approach is expected to play a pivotal role in the future of retinal diagnostics.

Key Market Players

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation (Centervue SpA)
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems (Synergy Medical) LLC

Report Scope:

In this report, the Global Retinal Detachment Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Retinal Detachment Diagnostic Market, By Disease Type:

• Rhegmatogenous Retinal Detachment
• Exudative
• Serous or Secondary Retinal Detachment
• Tractional Retinal Detachment

Retinal Detachment Diagnostic Market, By Diagnostics:

• Fundus Photography
• Ophthalmoscopy
• Digital Retinal Camera
• Fluorescent Retinal Angiography
• Others

Retinal Detachment Diagnostic Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Retinal Detachment Diagnostic Market.

Available Customizations:

Global Retinal Detachment Diagnostic market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Retinal Detachment Diagnostic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment, Tractional Retinal Detachment)
  • 5.2.2. By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera, Fluorescent Retinal Angiography, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Retinal Detachment Diagnostic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Diagnostics
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Retinal Detachment Diagnostic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Diagnostics
  • 6.3.2. Canada Retinal Detachment Diagnostic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Diagnostics
  • 6.3.3. Mexico Retinal Detachment Diagnostic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Diagnostics

7. Europe Retinal Detachment Diagnostic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Retinal Detachment Diagnostic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. United Kingdom Retinal Detachment Diagnostic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. Italy Retinal Detachment Diagnostic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. France Retinal Detachment Diagnostic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. Spain Retinal Detachment Diagnostic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Diagnostics

8. Asia-Pacific Retinal Detachment Diagnostic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Retinal Detachment Diagnostic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. India Retinal Detachment Diagnostic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Japan Retinal Detachment Diagnostic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. South Korea Retinal Detachment Diagnostic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. Australia Retinal Detachment Diagnostic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Diagnostics

9. South America Retinal Detachment Diagnostic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Retinal Detachment Diagnostic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. Argentina Retinal Detachment Diagnostic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. Colombia Retinal Detachment Diagnostic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Diagnostics

10. Middle East and Africa Retinal Detachment Diagnostic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Retinal Detachment Diagnostic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Saudi Arabia Retinal Detachment Diagnostic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. UAE Retinal Detachment Diagnostic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Retinal Detachment Diagnostic Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Canon Medical Systems Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Carl Zeiss Meditec Inc.
• 14.3. Revenio Group Corporation (Centervue SpA)
• 14.4. Eyenuk Inc.
• 14.5. Essilor International SA
• 14.6. HealPros LLC
• 14.7. Millennium Surgical Corp.
• 14.8. ONL Therapeutics
• 14.9. Peek Vision Ltd
• 14.10.Parata Systems (Synergy Medical) LLC

15. Strategic Recommendations

16. About Us & Disclaimer